Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial

OBJECTIVE: To assess the incremental cost and cost-effectiveness of a restrictive versus a liberal red blood cell transfusion threshold after cardiac surgery. DESIGN: A within-trial cost-effectiveness analysis with a 3-month time horizon, based on a multicentre superiority randomised controlled tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokes, E A, Wordsworth, S, Bargo, D, Pike, K, Rogers, C A, Brierley, R C M, Angelini, G D, Murphy, G J, Reeves, B C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985876/
https://www.ncbi.nlm.nih.gov/pubmed/27481621
http://dx.doi.org/10.1136/bmjopen-2016-011311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985876/
https://www.ncbi.nlm.nih.gov/pubmed/27481621
http://dx.doi.org/10.1136/bmjopen-2016-011311

Ejemplares similares